Examination of TAR-independent trans activation by human immunodeficiency virus type 1 Tat in human glial cells

Journal of Neuroscience Research

Volumn 43, Issue 6, 1996, Pages 652-663

  Kim, Y S ^a   Panganiban, A T ^b  

^a Yonsei University College of Medicine   (South Korea)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

astroglia; envelope glycoprotein; human immunodeficiency virus type 1; persistent infection; Tat protein

Indexed keywords

TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; ASTROCYTE; CELL CULTURE; CENTRAL NERVOUS SYSTEM; EXON; GENE EXPRESSION; GENETIC TRANSFECTION; GLIA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; PERSISTENT INFECTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; RNA ANALYSIS; TRANSACTIVATION; TRANSCRIPTION INITIATION; VIRUS REPLICATION;

ASTROCYTOMA; CELL FUSION; GENE PRODUCTS, TAT; GENES, ENV; HELA CELLS; HIV-1; HUMANS; LUCIFERASES; NEUROGLIA; PLASMIDS; PRECIPITIN TESTS; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0029922190     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960315)43:6<652::AID-JNR2>3.0.CO;2-D     Document Type: Article

References (57)

1. Adachi A, Gendelman HE, Koenig S, Folks T, Wiley R, Rabson A, Martin MA, (1986): production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59:284-291.
2. Arya SK, Guo C, Josephs SF, Wong-Staal F (1985): Transactivator gene of a human T-lymphotropic virus type III (HTLV-III). Science 229:69-73.
3. Bagasra O, Khalili K, Seshamma T, Taylor JP, Pomerantz RJ (1992): TAR-independent replication of human immunodeficiency virus type 1 in glial cells. J Virol 66:7522-7528.
4. Berkhout B, Gatignol A, Rabson AB, Jeang K (1990): TAR independent activation of the HIV-1 LTR: evidence that Tat requires specific regions of the promoter. Cell 62:757-767.
5. Braddock M, Chambers A, Wilson W, Esnouf MP, Adams SE, Kingsman AJ, S. Kingsman M (1989): HIV-1 Tat "activates" presynthesized RNA in the nucleus. Cell 58:269-279.
6. Braddock M, Thorburn AM ,Chambers A, Elliott GD, Anderson GJ, Kingsman JA, Kingsman SM (1990): A nuclear translational block imposed by the HIV-1 U3 region is relieved by the TatTAR interaction. Cell 62:1123-1133.
7. Braddock M, Thorburn AM, Kingsman AJ, Kingsman SM (1991): Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity. Nature 350:439-441.
8. Buonaguro L, Barillari G, Chang HA, Bohan CA, Kao V, Morgan R, Gallo RC, Ensoli B (1992): Effects of the human immunodeficiency virus type 1 Tat protein of the expression of inflammatory cytokines. J Virol 66:7159-7167.
9. Chesebro B, Buller R, Portis J, Wehrly K (1990): Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. J Virol 64:215-221.
10. Chiodi F, Fuerstenberg S, Gidlund M, Åsjö B, Fenyö EM (1987): Infection of brain-derived cells with the human immunodeficiency virus. J Virol 61:1244-1247.
11. Chowdhury M, Taylor JP, Chang CF, Rappaport J, Khalili K (1992): Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J Virol 66:7355-7361.
12. Clapham PR, Weber JN, Whitby D, McIntosh K, Dalgleish AG, Madden PJ, Deen KC, Sweet RW, Weiss RA (1989): Soluble CD4 blocks the infectivity of diverse strains of HIV and SFV for T cells and monocytes but not for brain and muscle cells. Nature 337:368-370.
13. Cullen BR (1986): Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 46:973-982.
14. Cullen BR, Green WC (1989): Regulatory pathways governing HIV-1 replication. Cell 58:423-426.
15. Desai K, Loewenstein PM, Green M (1991): Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter [published erratum appears in Proc Natl Acad Sci USA 1991, 88:11589]. Proc Natl Acad Sci USA 88:8875-8879.
16. Dewhurst S, Sakai K, Bresser J, Stevenson M, Evinger-Hodges MJ, Volsky DJ (1987): Persistent productive infection of human glial cells by human immunodeficiency virus and by infectious molecular clones of HIV. J Virol 61:3774-3782.
17. Ensoli B, Barrilary G, Sallahuddin SZ, Gallo RC, Wong-Staal F (1990): Tat protein of HIV-1 stimulates growth of cells derived from Kaposi sarcoma lesions. Nature 345:84-86.
18. Fauci AS (1988): The human immunodeficiency virus infectivity and mechanisms of pathogenesis. Science 239:617-622.
19. Feinberg MB, Jarrett RF, Aldovini A, Gallo RC, Wong-Staal F (1986): HTLV-IH expression and production involve complex regulation at the levels of splicig and translation of viral RNA. Cell 46:807-817.
20. Feng S, Holland EC (1988): HTV-1 tat trans-activation requires the loop sequence within TAR. Nature 334:165-167.
21. Freed EO, Delwart EL, Buchschacher GL, Panganiban AT (1992): A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc Natl Acad Sci USA 89:70-74.
22. German CM, Moffat LF, Howard BH (1982): Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2:1044-1051.
23. Hauber J, Cullen BR (1988): Mutational analysis of the transactivation responsive region of the human immunodeficiency virus type 1 long terminal repeat. J Virol 62:673-679.
24. Ho D, Pomerantz RJ, Kaplan JC (1987): Pathogenesis of infection with human immunodeficiency virus. N Engt J Med 317:278-286.
25. Howcroft TK, Strebel K, Martin MA, Singer DS (1993): Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260:1320-1322.
26. Kim Y-S, Panganiban AT (1993): The full length Tat protein is required for TAR-independent, posttranscriptional transactivation of HIV env gene expression. J Virol 67:3739-3747.
27. Kim, Y-S, Risser R (1993): TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat protein. J Virol 67:239-248.
28. Kim Y-S (1994): Requirement of the human immunodeficiency virus type 1 env gene sequence for TAR-independent transactivation by Tat from the major immediate-early promoter of murine cytomegalovirus. Biochem Biophys Res Commun 203:1152-1159.
29. Kimpton J, Emerman M (1992): Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated b-galactosidase gene. J Virol 66:2232-2239.
30. Laspia MF, Rice AP, Mathews MB (1989): HTV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292.
31. Laspia MF, Rice AP, Mathews MB (1990): Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes Dev 4:2397-408.
32. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R (1986): The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
33. Maniatis T, Goodbourn S, Fischer JA (1987): Regulation of inducible and tissue-specific gene expression. Science 236:1237-1245.
34. Marciniak RA, Garcia-Blanco MA, Sharp PA (1990): Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus. Proc Natl Acad Sci USA 87:3624-3628.
35. Nelbock P, Dillon PJ, Perkins A, Rosen CA (1990): A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator. Science 248:1650-1653.
36. Pavlakis GN, Felber BK (1990): Regulation of expression of human immunodeficiency virus. New Biol 2:20-31.
37. Pomerantz RJ, Trono D, Feinberg MB, Baltimore D (1990): Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expressions molecular model for latency. Cell 62:1271-1276.
38. Ponten L, MacIntyre EH (1968): Longterm culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74:465-486.
39. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P (1988): The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586-592.
40. Puri R, Aggarwal BB (1992): HTV-1 tat gene regulated IL-4 receptors on a human B-lymphoblastoid cell line. Cancer Res 52:3787-3790.
41. Rosen CA, Pavlakis GN (1990): Tat and Rev: positive regulators of HIV gene expression. AIDS 4:499-509.
42. Rosen CA, Sodroski JG, Haseltine WA (1985): The location of cisacting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41:813-823.
43. Rosen CA, Sodroski JG, Goh WC, Dayton AI, Lippke J, Haseltine WI (1986): Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III. Nature 319:555-559.
44. Roy S, Parkin NT, Rosen C, Itovitch I, Sonenberg N (1990): Structural requirements for trans-activation of human immunodeficiency virus type I long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence. J Virol 64:1402-1406.
45. Selby MJ, Peterlin BM (1990): Trans-activation of HIV-1 Tat via a heterologous RNA binding protein. Cell 62:769-776.
46. Shastry KJ, Reddy RH, Pandita R, Totpal K, Aggarwall BB (1990): HIV tat gene induces TNF-β in a human B-lymphoblastoid cell line. J Biol Chem 265:20091-20093.
47. Sodroski J, Patarca R, Rosen C, Wong-Staal F, Haseltine W (1985a): Location of the trans-activation region on the genome of human T-cell lym-photropic virus type in. Science 229:74-77.
48. Sodroski J, Rosen C, Wong-Staal F, Salahuddin SZ, Popovic M, Arya S, Gallo RC, Haseltine WA (1985b): Transacting transcriptional regulation of Human T-cell leukemia virus type in long terminal repeat. Science 227:171-173.
49. Southgate C, Zapp ML, Green MR (1990): Activation of transcription by HIV-1 Tat protein gathered to nascent RNA through another protein. Nature 334:640-642.
50. Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K (1990): Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci USA 87:3479-3483.
51. Taylor JP, Pomerantz R, Bagasra O, Chowdhury M, Rappaport J, Khalili K, Amini S (1992): TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation. EMBO J 11:3395-3403.
52. Tornatore C, Nath A, Amemiya K, Major EO (1991): Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 65:6094-6100.
53. Varmus HE (1988): Regulation of HTV and HTLV gene expression. Genes Dev 3:1055-1062.
54. Week KM, Ampe C, Schultz SC, Steitz TA, Crothers DM (1990): Fragments of the HIV-1 Tat protein specifically bind TAR RNA. Science 249:1281-1285.
55. Westendorp MO, Weber ML, Frank RW, Krammer PH (1994): Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J Virol 68:4177-4185.
56. Wiley CA, Schrier RD, Nelson JA, Lambert PL, Oldstone MBA (1986): Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83:7089-7093.
57. Wright CM, Felber BK, Paskalis H, Pavlakis GN (1986): Expression and characterization of the transactivation of HTLV-III/LAV virus. Science 234:988-992.